1. Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy.
- Author
-
Gnocchi D, Sabbà C, Massimi M, and Mazzocca A
- Subjects
- Humans, Obesity complications, Carcinoma, Hepatocellular metabolism, Liver Neoplasms metabolism, Non-alcoholic Fatty Liver Disease metabolism, Metabolic Syndrome complications
- Abstract
Hepatocellular carcinoma is today the sixth leading cause of cancer-related death worldwide, despite the decreased incidence of chronic hepatitis infections. This is due to the increased diffusion of metabolic diseases such as the metabolic syndrome, diabetes, obesity, and nonalcoholic steatohepatitis (NASH). The current protein kinase inhibitor therapies in HCC are very aggressive and not curative. From this perspective, a shift in strategy toward metabolic therapies may represent a promising option. Here, we review current knowledge on metabolic dysregulation in HCC and therapeutic approaches targeting metabolic pathways. We also propose a multi-target metabolic approach as a possible new option in HCC pharmacology.
- Published
- 2023
- Full Text
- View/download PDF